Insider Transactions in Q3 2018 at Amgen Inc (AMGN)
Insider Transaction List (Q3 2018)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 10
2018
|
Rebecca M Henderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
977
-6.03%
|
$188,561
$193.97 P/Share
|
Aug 10
2018
|
Rebecca M Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+15.63%
|
$189,000
$63.11 P/Share
|
Aug 06
2018
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,586
-13.77%
|
$1,297,442
$197.99 P/Share
|
Aug 01
2018
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,382
-12.39%
|
$1,446,872
$196.55 P/Share
|
Aug 01
2018
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,982
-5.41%
|
$388,472
$196.55 P/Share
|
Jul 31
2018
|
Brian Druker Director |
BUY
Grant, award, or other acquisition
|
Direct |
678
+50.0%
|
-
|
Jul 31
2018
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
89
+3.33%
|
-
|
Jul 31
2018
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+4.61%
|
-
|
Jul 16
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.65%
|
$297,375
$195.71 P/Share
|